Metabolic Profile of Alzheimer's Disease: Is 10-Hydroxy-2-decenoic Acid a Pertinent Metabolic Adjuster?

Overview

Journal Metabolites

Publisher MDPI

Date 2023 Aug 25

PMID 37623897

Authors

Yuan Gong

Hongjie Luo

Zeju Li

Yijun Feng

Zhen Liu

Jie Chang

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) represents a significant public health concern in modern society. Metabolic syndrome (MetS), which includes diabetes mellitus (DM) and obesity, represents a modifiable risk factor for AD. MetS and AD are interconnected through various mechanisms, such as mitochondrial dysfunction, oxidative stress, insulin resistance (IR), vascular impairment, inflammation, and endoplasmic reticulum (ER) stress. Therefore, it is necessary to seek a multi-targeted and safer approach to intervention. Thus, 10-hydroxy-2-decenoic acid (10-HDA), a unique hydroxy fatty acid in royal jelly, has shown promising anti-neuroinflammatory, blood-brain barrier (BBB)-preserving, and neurogenesis-promoting properties. In this paper, we provide a summary of the relationship between MetS and AD, together with an introduction to 10-HDA as a potential intervention nutrient. In addition, molecular docking is performed to explore the metabolic tuning properties of 10-HDA with associated macromolecules such as GLP-1R, PPARs, GSK-3, and TREM2. In conclusion, there is a close relationship between AD and MetS, and 10-HDA shows potential as a beneficial nutritional intervention for both AD and MetS.

Citing Articles

Royal Jelly: Biological Action and Health Benefits.

Orsolic N, Jazvinscak Jembrek M Int J Mol Sci. 2024; 25(11).

PMID: 38892209 PMC: 11172503. DOI: 10.3390/ijms25116023.

References

Galea I . The blood-brain barrier in systemic infection and inflammation. Cell Mol Immunol. 2021; 18(11):2489-2501. PMC: 8481764. DOI: 10.1038/s41423-021-00757-x. View

Morabito M, Berman D, Schneider R, Zhang Y, Leibel R, Small S . Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease. Neurobiol Dis. 2014; 65:188-92. PMC: 4235335. DOI: 10.1016/j.nbd.2013.12.017. View

Abolhassani N, Leon J, Sheng Z, Oka S, Hamasaki H, Iwaki T . Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain. Mech Ageing Dev. 2016; 161(Pt A):95-104. DOI: 10.1016/j.mad.2016.05.005. View

Calvo-Rodriguez M, Bacskai B . Mitochondria and Calcium in Alzheimer's Disease: From Cell Signaling to Neuronal Cell Death. Trends Neurosci. 2020; 44(2):136-151. DOI: 10.1016/j.tins.2020.10.004. View

Hamilton K, Harvey J . The Neuronal Actions of Leptin and the Implications for Treating Alzheimer's Disease. Pharmaceuticals (Basel). 2021; 14(1). PMC: 7827292. DOI: 10.3390/ph14010052. View

Verdile G, Keane K, Cruzat V, Medic S, Sabale M, Rowles J . Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease. Mediators Inflamm. 2015; 2015:105828. PMC: 4674598. DOI: 10.1155/2015/105828. View

Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T . Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. Cell Res. 2019; 29(10):787-803. PMC: 6796854. DOI: 10.1038/s41422-019-0216-x. View

Shinohara M, Tachibana M, Kanekiyo T, Bu G . Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies. J Lipid Res. 2017; 58(7):1267-1281. PMC: 5496044. DOI: 10.1194/jlr.R075796. View

Chi H, Yao R, Sun C, Leng B, Shen T, Wang T . Blood Neuroexosomal Mitochondrial Proteins Predict Alzheimer Disease in Diabetes. Diabetes. 2022; 71(6):1313-1323. DOI: 10.2337/db21-0969. View

10.

Wang J, Yuan Y, Cai R, Huang R, Tian S, Lin H . Association between Plasma Levels of PAI-1, tPA/PAI-1 Molar Ratio, and Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus. J Alzheimers Dis. 2018; 63(2):835-845. DOI: 10.3233/JAD-171038. View

11.

Puente E, Silverstein J, Bree A, Musikantow D, Wozniak D, Maloney S . Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia. Diabetes. 2010; 59(4):1055-62. PMC: 2844814. DOI: 10.2337/db09-1495. View

12.

Montagne A, Barnes S, Sweeney M, Halliday M, Sagare A, Zhao Z . Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015; 85(2):296-302. PMC: 4350773. DOI: 10.1016/j.neuron.2014.12.032. View

13.

Kim S, Chae C, Lee H, Jung Y, Choi G, Kim J . Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1. Cell Death Dis. 2020; 11(6):469. PMC: 7303181. DOI: 10.1038/s41419-020-2663-1. View

14.

Khemka V, Bagchi D, Bandyopadhyay K, Bir A, Chattopadhyay M, Biswas A . Altered serum levels of adipokines and insulin in probable Alzheimer's disease. J Alzheimers Dis. 2014; 41(2):525-33. DOI: 10.3233/JAD-140006. View

15.

Nowell J, Blunt E, Gupta D, Edison P . Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease. Ageing Res Rev. 2023; 89:101979. DOI: 10.1016/j.arr.2023.101979. View

16.

Lin C, Nicol C, Cheng Y, Chen S, Yen C, Huang R . Rosiglitazone rescues human neural stem cells from amyloid-beta induced ER stress via PPARγ dependent signaling. Exp Cell Res. 2018; 370(2):312-321. DOI: 10.1016/j.yexcr.2018.06.033. View

17.

Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

18.

Shen H, Guan Q, Zhang X, Yuan C, Tan Z, Zhai L . New mechanism of neuroinflammation in Alzheimer's disease: The activation of NLRP3 inflammasome mediated by gut microbiota. Prog Neuropsychopharmacol Biol Psychiatry. 2020; 100:109884. DOI: 10.1016/j.pnpbp.2020.109884. View

19.

Velazquez R, Tran A, Ishimwe E, Denner L, Dave N, Oddo S . Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease. Neurobiol Aging. 2017; 58:1-13. PMC: 5819888. DOI: 10.1016/j.neurobiolaging.2017.06.003. View

20.

Hong S, Han K, Park S, Kim S, Kim N, Choi K . Gamma-Glutamyl Transferase Variability and Risk of Dementia in Diabetes Mellitus: A Nationwide Population-Based Study. J Clin Endocrinol Metab. 2020; 105(3). DOI: 10.1210/clinem/dgaa019. View